top of page

Media Partnership: ELRIG Drug Discovery 2025

High-End Science Communication for a Flagship Pharma R&D Conference

Background

ELRIG Drug Discovery is a pharma flagship event that is so vibrant you could call it a “Festival of Life Science”. Despite being very technical and rich in information (e.g. 15 scientific tracks and multiple parallel auditoriums), it is a network-driven, R&D-focused meeting where decisions, collaborations, and strategic directions in drug discovery and pharmaceutical research are shaped.

​

The event is highly popular, with rising attendance every year, attracting senior scientists, technology leads, platform heads, and decision-makers across biotech, pharma, CROs, and enabling technology providers.

​

In 2025, Zeeks – Art for Geeks partnered with ELRIG UK as a media and science communication partner for Drug Discovery 2025 in Liverpool, UK.

IMG-20251021-WA0003.jpg

Context: Drug Discovery 2025 as an

R&D Signal Hub

ELRIG Drug Discovery is a key event to understand where pharmaceutical R&D is heading.

 

The programme spanned:

  • advanced and human-relevant disease models

  • automation, robotics, and high-throughput screening

  • image-based phenotyping and quantitative biology

  • AI-enabled drug discovery and data integration

  • translational research and modality innovation

 

Attendees were not there to be “inspired”; they were there to benchmark technologies, identify collaborators, evaluate platforms, and track emerging trends across the discovery pipeline.

​

For an event of this calibre, media partnership is not about visibility alone - it is about accurate signal amplification to the right people in the life sciences ecosystem.

The Challenge: Communicating for Experts

Drug Discovery 2025 presented a very specific communication challenge:

  • The audience already understands the science

  • Oversimplification destroys credibility

  • Generic event coverage adds no value

  • Context, nuance, and trend awareness matter more than summaries

  • ​

ELRIG required a partner capable of operating inside the field.

Someone who understands:

  • how drug discovery workflows actually work

  • where image analysis, automation, and AI are converging

  • which technologies are mature, emerging, or overhyped

  • who the key players are, and why they matter

  • ​

This is where Zeeks comes in, with our tagline being more important than ever,

“Science, marketed right. By scientists, not stylists.​”

ELRIG.png

Zeeks’ Role: Domain-Fluent Science Communication

As a science communication agency specialising in life sciences, Zeeks supported ELRIG Drug Discovery 2025 through strategic dissemination for expert audiences.

The content included podcast interviews, blog posts, and editorial content, distributed across various platforms.

 

This meant:

  • providing behind-the-scenes insights from conference organisers

  • highlighting the event diversity

  • reaching relevant audiences across Zeeks' channels

 

The goal was to position Drug Discovery 2025 as a must-attend R&D convergence point, not just another conference.

Why Domain Knowledge Matters at This Level

Zeeks’ contribution was underpinned by the leadership of Dr Elisabeth Kugler, whose background in biomedical image analysis, quantitative biology, and research tool development. Which are topics directly aligned with the computational backbone of modern drug discovery.

​

This expertise enabled Zeeks to:

  • recognise methodological significance in real time

  • distinguish incremental advances from step-changes

  • contextualise image-based and AI-driven approaches within broader discovery pipelines

  • understand how vendors, academics, and pharma teams speak to each other (and why)

 

For an event where image data, automation, and computational analysis increasingly define discovery efficiency, this fluency was critical.

​

Outcomes: High-Signal Dissemination, Not Noise

The Zeeks x ELRIG Drug Discovery 2025 partnership delivered value in ways that matter to R&D ecosystems:

  • High-signal digital coverage that resonated with expert audiences

  • Sustained engagement across professional networks during and after the event

  • Content that remained relevant as a reference point after the event

Conclusion

ELRIG Drug Discovery 2025 required content and dissemination for insiders - people making decisions about platforms, pipelines, and partnerships.

 

This case study demonstrates Zeeks’ core value proposition:

  • science communication with domain expertise

  • fluency in drug discovery trends and technologies

  • understanding of who matters and why within R&D ecosystems

​

For organisations operating at the leading edge of pharma and biotech innovation, Zeeks provides communication that speaks the language of the field.

Screenshot 2024-02-22 140800.png

Book a FREE consultation

Book your FREE consultation today. During the call, we will get to know you, your business, and your science communication needs.

Or email us at info@zeeks-artforgeeks.com.

bottom of page